Advances in the management of HER2-positive early breast cancer

Erstveröffentlichung
2017Authors
Baselga, Jose
Coleman, Robert E.
Cortes, Javier
Janni, Wolfgang
Wissenschaftlicher Artikel
Published in
Critical Reviews in Oncology/Hematology ; 119 (2017). - S. 113-122. - ISSN 1040-8428. - eISSN 1879-0461
Link to publication
https://dx.doi.org/10.1016/j.critrevonc.2017.10.001Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: Breast cancer | HER2 | Trastuzumab | T-DM1 | Neratinib | Pertuzumab | Lapatinib | epidermal-growth-factor | pertuzumab plus trastuzumab | randomized phase-3 trial | open-label | adjuvant trastuzumab | double-blind | receptor heterodimerization | chemotherapy plus | tyrosine kinase | follow-up[DDC subject group]: DDC 610 / Medicine & health